Edition:
United States

Genesis Healthcare Inc (GEN.N)

GEN.N on New York Stock Exchange

2.54USD
4:02pm EDT
Change (% chg)

$0.01 (+0.40%)
Prev Close
$2.53
Open
$2.48
Day's High
$2.57
Day's Low
$2.48
Volume
59,171
Avg. Vol
57,910
52-wk High
$4.75
52-wk Low
$1.38

Latest Key Developments (Source: Significant Developments)

Genesis Healthcare reports Q4 revenue $1.4 bln
Wednesday, 22 Feb 2017 06:21pm EST 

Genesis Healthcare Inc : Genesis Healthcare reports fourth quarter and fiscal year end 2016 results . Q4 revenue $1.4 billion versus I/B/E/S view $1.4 billion . In 2017, genesis expects to divest 31 underperforming assets or assets in non-strategic markets . U.S. GAAP net income attributable To Genesis Healthcare in Q4 of 2016 was $22.5 million . Sees 2017 revenue $5,400.0 million to $5,600.0 million . Sees $50 million of overhead and net operating cost reductions in 2017 . Sees 2017 net loss attributed to GHC of $85.0 million to $74.0 million .FY2017 revenue view $5.64 billion -- Thomson Reuters I/B/E/S.  Full Article

Genesis Healthcare reports qtrly loss per share $0.23
Thursday, 3 Nov 2016 04:01pm EDT 

Genesis Healthcare Inc : Genesis healthcare reports third quarter 2016 results . US gaap net loss attributable to genesis healthcare in q3 of 2016 was $20.5 million versus gaap net loss of $29.0 million in q3 of 2015 . Genesis healthcare inc qtrly loss per share $0.23 . Genesis healthcare reports third quarter 2016 results .Q3 revenue $1.419 billion versus i/b/e/s view $1.39 billion.  Full Article

Genesis Healthcare reports Q2 cont ops loss per share $0.26
Thursday, 4 Aug 2016 04:35pm EDT 

Genesis Healthcare Inc : Genesis healthcare reports second quarter 2016 results . Qtrly revenue $1.44 billion versus $ 1.42 billion . Q2 earnings per share view $0.01, revenue view $1.40 billion -- Thomson Reuters I/B/E/S . Says reaffirms its previously announced guidance for fiscal 2016. .Qtrly loss per share $0.26 from continuing operations.  Full Article

Genesis Healthcare and some units enter into new term loan agreement
Monday, 1 Aug 2016 08:49am EDT 

Genesis Healthcare Inc : On July 29, 2016, co and certain of its units entered into four-year term loan agreement with HCRI Tucson Properties - SEC filing . New term loan agreement matures on July 29, 2020 . New term loan agreement provides for term loans in the aggregate principal amount of $120.0 million .Net proceeds of new term loan used to repay all outstanding term loans and obligations of co and its units under prior term loan.  Full Article

Genesis healthcare reports Q1 adjusted loss per share $0.01
Monday, 9 May 2016 06:02pm EDT 

Genesis Healthcare Inc : Genesis healthcare sees 2016 adjusted net revenues $5,650.0 million to $5,750.0 million; sees 2016 adjusted earnings per share between loss of $0.05 to profit of $0.08 . Fy2016 revenue view $5.77 billion -- Thomson Reuters I/B/E/S . Genesis healthcare reports first quarter 2016 results . Q1 adjusted loss per share $0.01 . Q1 earnings per share view $0.03 -- Thomson Reuters I/B/E/S .Q1 revenue $1.472 billion versus i/b/e/s view $1.43 billion.  Full Article

Genesis HealthCare Inc signs agreement to sell home health and hospice Operations
Wednesday, 9 Mar 2016 08:30am EST 

Genesis HealthCare Inc:Signs agreement to sell home health and hospice operations.Says deal valued at $84 million.Says genesis intends to use the sale proceeds to repay indebtedness.Says any remaining hospice operations in Arizona and Nevada will be closed.  Full Article

Genesis Healthcare, Inc reaffirms FY 2015 guidance
Thursday, 5 Nov 2015 04:03pm EST 

Genesis Healthcare, Inc:Reaffirms its previously announced FY 2015 adjusted EBITDAR guidance of $755.0 million to $770.0 million, adjusted EBITDA of $267.6 million to $282.6 million, and net income from continuing operations on a diluted basis of $0.34 to $0.39 per share.FY 2015 EPS of $0.37 - Thomson Reuters I/B/E/S.  Full Article

Genesis Healthcare, Inc Reaffirms FY 2015 EBITDAR guidance; Raises FY 2015 EPS guidance; slightly lowers FY 2015 EBITDA guidance
Thursday, 6 Aug 2015 05:29pm EDT 

Genesis Healthcare, Inc:Reaffirms FY 2015 pro forma adjusted EBITDAR of $755 million to $770 million.Expects FY 2015 adjusted EBITDA of $267.6 million to $282.6 million.Says adjusting its previous FY 2015 net income from continuing operations on a diluted basis from a range of $0.29 to $0.34 per share to a revised range of $0.34 to $0.39 per share.FY 2015 EBITDA of $274 million and EPS of $0.31 - Thomson Reuters I/B/E/S.  Full Article

Genesis Healthcare to acquire 24 skilled nursing facilities from Revera Inc
Monday, 15 Jun 2015 07:30am EDT 

Genesis Healthcare Inc:To acquire 24 skilled nursing facilities from Revera Inc.Deal for $240 million.Says expects the transaction will be accretive to 2016 earnings.Says will also acquire the operations of premier therapy, revera's contract rehabilitation business.Says Genesis expects to finance the transaction utilizing a bridge loan from Health Care REIT.Will subsequently refinance the bridge loan utilizing the hud financing program or other traditional mortgage financing.To acquire real estate of 20 of 24 facilities and will enter into a long-term lease agreement with Health Care REIT.Says expects to finance the transaction utilizing a bridge loan from hcn.  Full Article

Genesis Healthcare, Inc reaffirms FY 2015 EBITDA guidance; lowers FY 2015 EPS guidance - Conference Call
Friday, 8 May 2015 08:30am EDT 

Genesis Healthcare, Inc:Reaffirms FY 2015 pro forma adjusted EBITDAR of $755 million to $770 million and pro forma adjusted EBITDA of $268 million to $283 million.Says for FY 2015 earnings per share, it is adjusting guidance down $0.05 on either side of the range to $0.29 on the low end and $0.34 on the high end.FY 2015 EBITDA of $271 million and EPS of $0.29 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Genesis Healthcare and Kindred form strategic clinical collaboration

* Genesis Healthcare and Kindred form strategic clinical collaboration to improve quality, outcomes and care transitions across the post-acute continuum Source text for Eikon: Further company coverage: